Earnings History Data for TriSalus Life Sciences, Inc. (TLSI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
TriSalus Life Sciences, Inc.
TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | TLSI | TriSalus Life Sciences, Inc. | 130.73 | -0.40 | -0.36 | -0.13 | TriSalus Life Sciences GAAP EPS of -$0.12 beats by $0.23, revenue of $7.3M misses by $0.07M [11/14/2024 9:38 AM] |
4.02 | -0.48 (-10.67%) |
0.0 | 0.0 (0.00%) |
3.32 - 10.42 | 64,806 | 30,000 | 0 | ||
|
||||||||||||||||||
| 15-05-2024 | PM | TLSI | TriSalus Life Sciences, Inc. | 263.03 | -0.54 | 0.00 | 0.00 | TriSalus Life Sciences reports Q1 GAAP EPS of -$0.60, revenue of $6.5M [5/15/2024 8:40 AM] |
9.34 | -0.81 (-7.98%) |
0.0 | 0.0 (0.00%) |
3.32 - 16.24 | 33,139 | 20,000 | 0 | ||
| 01-04-2024 | PM | TLSI | TriSalus Life Sciences, Inc. | 248.43 | -1.56 | 0.00 | 0.00 | TriSalus Life Sciences GAAP EPS of -$1.56 [4/1/2024 10:20 AM] |
10.18 | 0.43 (4.42%) |
10.00 | 0.25 (2.56%) |
3.32 - 16.24 | 37,596 | 60,000 | 349 | ||
| 14-11-2023 | PM | TLSI | TriSalus Life Sciences, Inc. | 105.00 | -0.13 | 0.00 | 0.00 | TriSalus Life Sciences GAAP EPS of -$0.13, revenue of $5.2M [11/14/2023 8:10 AM] |
4.00 | -0.01 (-0.17%) |
0.0 | 0.0 (0.00%) |
3.66 - 16.24 | 16,170 | 40,000 | 0 | ||